# Beow Y. Yeap

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/beow-y-yeap/

## Facts

| Field | Value |
| --- | --- |
| Citations | 25,824 |
| Field | Lung Cancer Treatments and Mutations |
| h-index | 85 |
| i10-index | 173 |
| Last Known Institution | Massachusetts General Hospital |
| OpenAlex ID | https://openalex.org/A5114045816 |
| Works | 453 |

## Researcher papers

- [Clinical Features and Outcome of Patients With Non–Small-Cell Lung Cancer Who Harbor <i>EML4-ALK</i>](https://scholariq.org/papers/clinical-features-and-outcome-of-patients-with-non-small-cell-lung-cancer-who/)
- [<i>EGFR</i> Mutations and <i>ALK</i> Rearrangements Are Associated with Low Response Rates to PD-1 Pathway Blockade in Non–Small Cell Lung Cancer: A Retrospective Analysis](https://scholariq.org/papers/i-egfr-i-mutations-and-i-alk-i-rearrangements-are-associated-with-low-response/)
- [Effect of crizotinib on overall survival in patients with advanced non-small-cell lung cancer harbouring ALK gene rearrangement: a retrospective analysis](https://scholariq.org/papers/effect-of-crizotinib-on-overall-survival-in-patients-with-advanced-non-small/)
- [Exon 19 Deletion Mutations of Epidermal Growth Factor Receptor Are Associated with Prolonged Survival in Non–Small Cell Lung Cancer Patients Treated with Gefitinib or Erlotinib](https://scholariq.org/papers/exon-19-deletion-mutations-of-epidermal-growth-factor-receptor-are-associated/)
- [Combined Vascular Endothelial Growth Factor Receptor and Epidermal Growth Factor Receptor (EGFR) Blockade Inhibits Tumor Growth in Xenograft Models of EGFR Inhibitor Resistance](https://scholariq.org/papers/combined-vascular-endothelial-growth-factor-receptor-and-epidermal-growth-factor/)
- [Patterns of Metastatic Spread and Mechanisms of Resistance to Crizotinib in <i>ROS1</i>-Positive Non–Small-Cell Lung Cancer](https://scholariq.org/papers/patterns-of-metastatic-spread-and-mechanisms-of-resistance-to-crizotinib-in-i/)
- [Combination Olaparib and Temozolomide in Relapsed Small-Cell Lung Cancer](https://scholariq.org/papers/combination-olaparib-and-temozolomide-in-relapsed-small-cell-lung-cancer/)

## Researcher topics

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Lung Cancer Research Studies](https://scholariq.org/topics/lung-cancer-research-studies/)
- [Occupational and environmental lung diseases](https://scholariq.org/topics/occupational-and-environmental-lung-diseases/)
- [Medical Imaging and Pathology Studies](https://scholariq.org/topics/medical-imaging-and-pathology-studies/)
- [Lung Cancer Diagnosis and Treatment](https://scholariq.org/topics/lung-cancer-diagnosis-and-treatment/)

## Researcher university

- [Massachusetts General Hospital](https://scholariq.org/institutions/massachusetts-general-hospital/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.